EMEDICS LTD - Accounts

EMEDICS LTD
Contents Page
For the year ended 28 February 2025

Accountants' report	1
Statement of financial position	2
Notes to the financial statements	3

EMEDICS LTD Accountants' Report For the year ended 28 February 2025
Accountants report You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Doyles 28 February 2025 .................................................... Doyles 51 Station Road Marston Green Birmingham West Midlands B37 7AB 31 October 2025 1

EMEDICS LTD
Accountants' Report
For the year ended 28 February 2025

Accountants report
You consider that the company is exempt from an audit for the year ended 28 February 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Doyles
28 February 2025

....................................................
Doyles
51 Station Road
Marston Green
Birmingham
West Midlands
B37 7AB
31 October 2025

1

EMEDICS LTD
Statement of Financial Position
As at 28 February 2025

	Notes	2025 £	2024 £
Fixed assets
Tangible fixed assets	3	1,524	1,982
		1,524	1,982
Current assets
Debtors		8	92
Cash at bank and in hand		780	373
		788	465
Creditors: amount falling due within one year		(861)	(1,122)
Net current assets		(73)	(657)

Total assets less current liabilities		1,451	1,325
Net assets		1,451	1,325

Capital and reserves
Called up share capital	4	1	1
Profit and loss account		1,450	1,324
Shareholders' funds		1,451	1,325

For the year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the director on 31 October 2025 and were signed by:

-------------------------------
Andrew Lloyd JONES
Director

2

EMEDICS LTD
Notes to the Abridged Financial Statements
For the year ended 28 February 2025

General Information

EMEDICS LTD is a private company, limited by shares, registered in England and Wales, registration number 13892677, registration address Suite 2A Blackthorn House, St. Pauls Square , Birmingham, West Midlands, B3 1RL. The trading address of the company is 42 Bushbury Croft, Birmingham, West Midlands, B37 6RH.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Computer Equipment	25% Straight Line
Plant and Machinery	25% Straight Line

2.	Average number of employees Average number of employees during the year was 1 (2024 : 1).

3.

Tangible fixed assets

Cost or valuation	Plant and Machinery	Computer Equipment	Total
	£	£	£
At 01 March 2024	1,489	1,356	2,845
Additions	320	-	320
Disposals	-	-	-
At 28 February 2025	1,809	1,356	3,165
Depreciation
At 01 March 2024	310	553	863
Charge for year	439	339	778
On disposals	-	-	-
At 28 February 2025	749	892	1,641
Net book values
Closing balance as at 28 February 2025	1,060	464	1,524
Opening balance as at 01 March 2024	1,179	803	1,982

4.

Share Capital

Allotted, called up and fully paid	2025 £		2024 £
1 Class A share of £1.00 each	1		1
	1		1

3

Registered Number: 13892677
England and Wales
EMEDICS LTD

Abridged Accounts

Period of accounts Start date: 01 March 2024 End date: 28 February 2025